## Preoperative Embolization in Nasopharyngeal Angiofibroma ### Role of Embolization **Key Point:** Preoperative transarterial embolization is the standard of care for nasopharyngeal angiofibroma (NAF) to reduce intraoperative blood loss and improve surgical visualization. ### Embolic Agents for NAF | Agent | Particle Size | Permanence | Clinical Use in NAF | Advantages | Disadvantages | |-------|---------------|-----------|---------------------|------------|----------------| | **Polyvinyl Alcohol (PVA)** | 150–1000 μm | Permanent | **Gold standard** | Permanent occlusion, prevents recanalization, cost-effective | Risk of distal embolization, non-retrievable | | Gelfoam | Variable | Temporary (2–6 weeks) | Adjunctive only | Biodegradable, low cost | Temporary effect, inadequate for NAF | | Sodium tetradecyl sulfate | — | Sclerosant | Variceal bleeding, not NAF | — | Not suitable for vascular tumors; causes thrombophlebitis | | Cyanoacrylate glue | — | Permanent | Rarely used in NAF | Permanent | Risk of catheter adhesion, unpredictable distribution | ### Why PVA is the Preferred Agent **High-Yield:** PVA particles (150–1000 μm) achieve permanent vascular occlusion by: 1. Lodging in the feeding arteries (typically branches of the maxillary artery) 2. Triggering foreign body reaction and endothelial proliferation 3. Preventing tumor neovascularization and recanalization **Clinical Pearl:** Embolization is performed 24–48 hours before surgery to allow stabilization of the thrombus and reduce the risk of rebleeding during surgical manipulation. ### Timing and Outcomes **Key Point:** Preoperative embolization reduces intraoperative blood loss by 50–80% and improves surgical access, reducing operative time and morbidity. **Mnemonic: PVA for NAF** — **P**olyvinyl **A**lcohol is the **N**asopharyngeal **A**ngiofibroma **F**irst choice.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.